The US government to pass new measures that make prosecuting
animal-rights activists who target enterprises much easier. The
move has lead critics to warn that peaceful demonstrators would be
labelled as terrorists.
Accelrys are to expand its Discovery Studio software environment
with new and enhanced life science modelling and simulation
functionality, which is set to deliver a broader range of tools for
drug discovery in one environment.
Asterand is to make available novel research materials to be used
in the investigation of rheumatoid arthritis, osteoarthritis,
cancer and other diseases making available a range of cell material
that is currently difficult to obtain.
Ground Zero Pharmaceuticals (GZP) has announced an expansion to the
services it offers enabling the expansion into more of its clients'
late-stage development programs, with the potential for creating
submissions that lead to...
Argos Therapeutics has been awarded a $21m (€17.2m) National
Institute of Health contract to develop novel HIV immunotherapy
candidates in a deal that could result in greater, more potent
next-generation product candidates.
A recent report that focuses on international research and
development trends has placed China as the country gaining
significant grounds on the US in terms of R&D spending and
Curalogic, a Danish biotechnology company, has appointed SAFC's
Pharma business segment to provide protein isolation, extraction
and purification services as part of its product development to
treat Allergic Rhinitis.
For pharma companies that are hesitant about outsourcing during the
drug discovery stage, a world of opportunity awaits.
OutsourcingPharma.com gives a brief run down of what kinds of
services are on offer, as well as a few potential...
Millipore has now made available its GPCRProfiler screening service
that allows more accurate characterisation of lead compounds
enabling pharmaceutical and biotechnology companies to accelerate
their lead optimisation efforts.
According to the CEO and Chairman of pharmaceutical giant Eli
Lilly, the biomedical breakthroughs that are occurring within the
industry are transforming medicine and promise to ease the
challenges facing an aging population.